DENVER — Akerna (Nasdaq: KERN), a leading enterprise software company and the developer of the most comprehensive technology infrastructure, ecosystem, and compliance engine powering the global cannabis industry, today announces the appointment of the Company’s current COO, Ray Thompson, as Akerna’s President and COO effective today, January 20.
Mr. Thompson brings a wealth of company knowledge and experience, having overseen the day-to-day operations of Akerna and its portfolio of brands as Akerna’s COO since 2018. His proven record of leadership is evident in Akerna’s recent achievements including the successful integration of six acquired companies, the expansion of Akerna products available to the enterprise sector, and the alignment and optimization of internal operations and processes.
“The leadership and commitment Ray has demonstrated over his years as COO of Akerna have been instrumental to getting us to where we are today,” says Jessica Billingsley, Chair and CEO of Akerna. “I am excited to leverage his expertise in new ways to bring Akerna into our next phase of development.”
“As we look forward, we must zero in on what Akerna uniquely contributes to the world,” added Mr. Thompson. “As the company with the most comprehensive cannabis-specific software solution on the market, pre-license and post-license consulting services, and robust data analytics, we are uniquely positioned to fully serve the evolving cannabis industry of today and tomorrow. I welcome this opportunity to lead the revenue and operations teams into the next phase of Akerna.”
About Akerna:
Akerna (Nasdaq: KERN) is an enterprise software company focused on compliantly serving the cannabis, hemp, and CBD industry. First launched in 2010, Akerna has tracked more than $30 billion in cannabis sales to date and is the first cannabis software company listed on Nasdaq. Using connected data and information to propel the cannabis industry forward, Akerna empowers businesses, governments, patients, and consumers to make smart decisions.
The Company’s cornerstone technology, MJ Platform, the world’s leading infrastructure as a service platform, powers retailers, manufacturers, brands, distributors, and cultivators. Akerna also offers a complete suite of professional consulting services and data analytics for businesses as well as solo sciences, Leaf Data Systems, Trellis, Ample Organics, Viridian Sciences and 365 Cannabis.
For more information, visit https://www.akerna.com/.
Forward-Looking Statements
Certain statements made in this release and any accompanying statements by management are “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. Such forward-looking statements include Akerna’s potential business strengths in the market and any other statements expressing the views of Akerna’s management on future business results or strategy. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of significant known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Akerna’s control, that could cause actual results or outcomes (including, without limitation, the results of Akerna’s contracts, strategic initiatives, and business plans as described herein) to differ materially from those discussed in the forward-looking statements. Important factors, among others that may affect actual results or outcomes, include (i) Akerna’s ability to recognize the anticipated benefits of being a public company, (ii) competition, (iii) Akerna’s ability to grow and manage growth profitably, (iv) Akerna’s ability to maintain relationships with customers and suppliers and retain its management and key employees, (v) costs related to being a public company, (vi) changes in applicable laws or regulations, (vii) Akerna’s ability to identify, complete and integrate acquisitions, including Viridian, and achieve expected synergies and operating efficiencies in connection with acquired businesses, (viii) and other risks and uncertainties disclosed from time to time in Akerna’s filings with the U.S. Securities and Exchange Commission, including those under “Risk Factors” therein. Actual results, performance, or achievements may differ materially, and potentially adversely, from any projections and forward-looking statements and the assumptions on which those vary from forward-looking statements are based. There can be no assurance that the data contained herein is reflective of future performance to any degree. You are cautioned not to place undue reliance on forward-looking statements as a predictor of future performance as projected financial and other information, are based on estimates and assumptions that are inherently subject to various significant risks, uncertainties and other factors, many of which are beyond Akerna’s control. All information herein speaks only as of the date hereof, in the case of information about Akerna, or the date of such information, in the case of information from persons other than Akerna. Akerna undertakes no duty to update or revise the information contained herein. Forecasts and estimates regarding Akerna’s industry and end markets are based on sources believed to be reliable; however, there can be no assurance these forecasts and estimates will prove accurate in whole or in part.
- Nebraska medical cannabis backers file legal challenge to petition process
Supporters of medical marijuana in Nebraska have launched a legal challenge to the state’s requirement that 5% of registered voters in at least 38 counties sign a petition to get the measure before voters on the ballot. - N.J. lawmakers seek to curb cannabis use
As New Jersey nears the end of its first month of legal recreational marijuana sales, lawmakers have introduced a series of bills aimed at restricting what types of workers can use cannabis off the job. - Missouri House votes to require disclosure of medical cannabis ownership records
The Missouri House voted overwhelmingly Tuesday to require state regulators to disclose ownership information for businesses granted medical marijuana licenses that the state has withheld from public view. - Nebraska medical cannabis group calls for ‘grassroots’ effort after losing donor
Unable to raise $1 million to replace funds from a major donor who died, Nebraskans for Medical Marijuana issued a plea Friday for supporters of the cause to take up petitions and gather signatures. - Lawmaker says GOP resistance may doom Missouri cannabis legalization
A Republican lawmaker pushing legislation to legalize recreational marijuana in Missouri says his bill is in jeopardy because of stall tactics by his GOP colleagues and the insistence of the House floor leader that it include license caps. - SD cannabis legalization campaign to submit signatures for November
Today, South Dakotans for Better Marijuana Laws, the political group that led the 2020 campaign to legalize cannabis in South Dakota, submitted petitions to place an adult-use cannabis legalization initiated measure on the November 2022 ballot. - NH senate votes down legal cannabis bills, ending chances for 2022
The New Hampshire Senate voted down two bills to legalize cannabis Thursday, likely heading off the last opportunities for legalization in the Granite State this year. - Last Prisoner Project: Taking Real Action to Help Cannabis Prisoners
“It really remains a fundamental injustice,” said Stephen Post, of America’s criminalization of cannabis. “We’re really helping to try to turn around those injustices.” Post works as a campaign manager for Last Prisoner Project (LPP), a nonprofit assisting cannabis prisoners. - Federal attempts to legalize cannabis flail, while public support grows
Across the country, attitudes toward cannabis are becoming more permissive and accepting, but partisan gridlock in Congress virtually ensures that legislation to decriminalize marijuana will languish and die in the U.S. Senate. - Wisconsin GOP medical cannabis bill gets 4/20 public hearing
The bill, authored by Sen. Mary Felzkowski (R-Irma), would legalize medicinal use of cannabis under specific conditions. Patients would need to be registered, and the cannabis must be in the form of a liquid, oil, pill, tincture or topical ointment.